Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-21

Clinical Trial Update: Expanded Use in Persistent (B. Microti) Babesiosis

View source ↗

Summary

The clinical trial update indicates an expanded use of a therapeutic in persistent Babesiosis caused by Babesia microti.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: 60 Degrees Pharmaceuticals LLC | Conditions: Persistent Babesiosis | Status: AVAILABLE